{"id":"https://openalex.org/W7225196162","doi":"https://doi.org/10.5281/zenodo.23910553","title":"Beyond the Expected: Life-Threatening Immune-Related Adverse Events from Checkpoint Blockade \u2014 A Case Series","display_name":"Beyond the Expected: Life-Threatening Immune-Related Adverse Events from Checkpoint Blockade \u2014 A Case Series","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225196162","doi":"https://doi.org/10.5281/zenodo.23910553"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23910553","doi":"https://doi.org/10.5281/zenodo.23910553","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23910553","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23910553","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5117597448","display_name":"Punam Rabha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Punam Rabha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031032662","display_name":"Ashutosh Jain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashutosh Jain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031092722","display_name":"Jerryes Pious Wisely","orcid":"https://orcid.org/0000-0003-0766-6713","observed_orcids":["https://orcid.org/0000-0003-0766-6713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerryes Pious Wisely","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160473953","display_name":"Narendra Bhardwaj","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Narendra Bhardwaj","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160567809","display_name":"Vinod Raina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinod Raina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82556267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dostarlimab","display_name":"dostarlimab","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pd-1-pd-l1-inhibitors","display_name":"PD-1/PD-L1 inhibitors","score":0.8130000233650208},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.5320000052452087},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.8679999709129333},{"id":"https://openalex.org/keywords/epidermal-necrosis","display_name":"epidermal necrosis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/immunotherapy-safety","display_name":"immunotherapy safety","score":0.45399999618530273},{"id":"https://openalex.org/keywords/endocrine-toxicity","display_name":"endocrine toxicity","score":0.36800000071525574},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hyponatremia","display_name":"hyponatremia","score":0.722000002861023},{"id":"https://openalex.org/keywords/adrenal-insufficiency","display_name":"adrenal insufficiency","score":0.878000020980835},{"id":"https://openalex.org/keywords/hypogonadotropic-hypogonadism","display_name":"hypogonadotropic hypogonadism","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9193000197410583},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.6588000059127808},{"id":"https://openalex.org/C2780194577","wikidata":"https://www.wikidata.org/wiki/Q4120169","display_name":"Hypophysitis","level":4,"score":0.621999979019165},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5752000212669373},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5357000231742859},{"id":"https://openalex.org/C2781283889","wikidata":"https://www.wikidata.org/wiki/Q1130148","display_name":"Diabetic ketoacidosis","level":3,"score":0.5254999995231628},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5160999894142151},{"id":"https://openalex.org/C2781107259","wikidata":"https://www.wikidata.org/wiki/Q5508364","display_name":"Fulminant","level":2,"score":0.5139999985694885},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.46369999647140503},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.42340001463890076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4212000072002411},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4106000065803528},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3425999879837036},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3424000144004822},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.3407000005245209},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.33709999918937683},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.3262999951839447},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.32019999623298645},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.2953999936580658},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.29260000586509705},{"id":"https://openalex.org/C2778168870","wikidata":"https://www.wikidata.org/wiki/Q6725808","display_name":"Maculopapular rash","level":3,"score":0.28940001130104065},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.28859999775886536},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.2858000099658966},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.2808000147342682},{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.2689000070095062},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.259799987077713},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25780001282691956},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.2535000145435333}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23910553","doi":"https://doi.org/10.5281/zenodo.23910553","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23910553","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23910554","doi":"https://doi.org/10.5281/zenodo.23910554","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23910554","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23910553","doi":"https://doi.org/10.5281/zenodo.23910553","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23910553","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7161038192","https://openalex.org/W7140228041","https://openalex.org/W3157517016","https://openalex.org/W7131073988","https://openalex.org/W7140307905","https://openalex.org/W2886455141","https://openalex.org/W7161286141","https://openalex.org/W3159401968","https://openalex.org/W4308142103","https://openalex.org/W4406296866"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Immune":[2],"checkpoint":[3,289],"inhibitors":[4],"(ICIs)":[5],"have":[6],"transformed":[7],"the":[8,93,145,211],"management":[9],"of":[10,66,127,188,266],"multiple":[11],"solid":[12],"tumors,":[13],"but":[14],"their":[15],"use":[16],"is":[17],"accompanied":[18],"by":[19],"immune-related":[20,291],"adverse":[21,292],"events":[22],"(irAEs)":[23],"that":[24],"can":[25,237,259],"affect":[26],"virtually":[27],"any":[28],"organ":[29],"system.":[30],"Although":[31],"most":[32],"irAEs":[33,55],"are":[34,38,97],"low-grade,":[35],"a":[36,62,80,103,154,192,271],"minority":[37],"severe":[39,122],"or":[40,74],"life-threatening":[41],"and":[42,87,96,124,132,144,172,185,229,241,249,258,276,282],"require":[43],"prompt":[44],"recognition.":[45],"We":[46,60],"describe":[47],"three":[48,67],"patients":[49,68],"who":[50],"developed":[51,114,205],"distinct,":[52],"uncommon,":[53],"high-severity":[54],"during":[56],"ICI":[57,235],"therapy.":[58],"Methods:":[59],"report":[61],"retrospective":[63],"case":[64],"series":[65],"treated":[69],"with":[70,106,121,168,197,247,270],"programmed":[71],"death-1":[72],"(PD-1)":[73],"PD-1/PD-ligand":[75],"1":[76],"(PD-L1)\u2013directed":[77],"therapy":[78,162,236],"at":[79,149],"tertiary":[81],"oncology":[82],"referral":[83],"center.":[84],"Clinical,":[85],"laboratory,":[86],"imaging":[88],"data":[89],"were":[90],"extracted":[91],"from":[92],"medical":[94,263],"record":[95],"presented":[98,167],"descriptively.":[99],"Results:":[100],"Case":[101,152,190],"1,":[102],"54-year-old":[104],"man":[105],"resected":[107],"clear-cell":[108],"renal-cell":[109],"carcinoma":[110],"receiving":[111,195],"adjuvant":[112],"pembrolizumab,":[113],"ICI-induced":[115],"hypophysitis":[116],"after":[117,160,210,255],"13":[118],"cycles,":[119],"presenting":[120],"hyponatremia":[123],"biochemical":[125],"evidence":[126],"central":[128],"hypothyroidism,":[129],"hypogonadotropic":[130],"hypogonadism,":[131],"secondary":[133],"adrenal":[134],"insufficiency;":[135],"pituitary":[136],"MRI":[137],"was":[138,142,177,231],"normal.":[139],"Hormone":[140],"replacement":[141],"initiated":[143],"patient":[146],"remained":[147],"disease-free":[148],"1-year":[150],"follow-up.":[151],"2,":[153],"74-year-old":[155],"woman":[156,194],"on":[157],"maintenance":[158],"pembrolizumab":[159],"trimodality":[161],"for":[163,199,274],"esophageal":[164],"adenosquamous":[165],"carcinoma,":[166,204],"fulminant":[169,245,295],"insulin-deficient":[170],"diabetes":[171,246],"diabetic":[173,297],"ketoacidosis":[174],"(DKA);":[175],"C-peptide":[176],"nearly":[178],"undetectable.":[179],"She":[180],"required":[181],"prolonged":[182],"subcutaneous":[183],"insulin":[184],"permanent":[186],"discontinuation":[187],"immunotherapy.":[189],"3,":[191],"68-year-old":[193],"dostarlimab":[196,230,302],"chemotherapy":[198],"metastatic":[200],"high-grade":[201],"serous":[202],"endometrial":[203],"an":[206],"extensive":[207,250],"maculopapular":[208],"eruption":[209],"second":[212],"dose.":[213],"Skin":[214],"biopsy":[215],"showed":[216],"full-thickness":[217],"epidermal":[218],"necrosis;":[219],"high-dose":[220],"systemic":[221],"corticosteroids":[222],"produced":[223],"gradual":[224],"resolution":[225],"over":[226],"2\u20133":[227],"months,":[228],"permanently":[232],"discontinued.":[233],"Conclusions:":[234],"produce":[238],"rare,":[239],"severe,":[240],"organ-specific":[242],"irAEs\u2014including":[243],"hypophysitis,":[244],"DKA,":[248],"cutaneous":[251,299],"eruptions\u2014that":[252],"may":[253,283],"occur":[254],"variable":[256],"latency":[257],"mimic":[260],"other":[261],"acute":[262],"conditions.":[264],"Awareness":[265],"these":[267],"presentations,":[268],"coupled":[269],"low":[272],"threshold":[273],"endocrine":[275],"dermatologic":[277],"evaluation,":[278],"allows":[279],"earlier":[280],"diagnosis":[281],"reduce":[284],"irAE-associated":[285],"morbidity.":[286],"Keywords:":[287],"immune":[288],"inhibitors;":[290],"events;":[293],"hypophysitis;":[294],"diabetes;":[296],"ketoacidosis;":[298],"toxicity;":[300],"pembrolizumab;":[301]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}